TORONTO, March 3, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of ...

With over 1,250 studies on hydrogen therapy, there’s growing interest in its benefits. Results may vary and research is ongoing for long term benefits. It has solid 8 ppm of molecular hydrogen ...

All intellectual and work property derived from DiagnaMed’s research activities in amyotrophic lateral sclerosis (ALS) and its Orphan Drug Designation (ODD) for molecular hydrogen in the ...